ACTIVE PHARMACEUTICAL INGRADIENTS* THERAPEUTIC CATEGORY Commercial Scale Alendronate Sodium+ Artesunate Azithromycin dihydrate Centrizine dihydrochloride+ Coenzyme Q10 Erythromycin Base+ Erythromycin Estolate+ Erythromycin Ethyl Succinate+ Erythromycin Oxime Erythromycin Phosphate Erythromycin Propionate Erythromycin Stearate+ Isoniazid Lisinopril dihydrate + Losartan potassium+ Pioglitazone hydrochloride Potassium iodide Pyrazinamide# Rifampicin Roxithromycin+ Sodium iodide Valproic acid Venlafaxine hydrochloride+ Zopiclone# Antiosteoporotic Antimalarial Antibiotic Antibiotic Neutraceutical Antibiotic Antibiotic Antibiotic Antibiotic Antibiotic Antibiotic Antibiotic Antitubecular Antihypertensive Antihypertensive Antidiabetic Dietary supplement Antitubercular Antitubercular Antibiotic Dietary supplement Antiepileptic Antidepressant Sedative, Hypnotic INTERMEDIATES FOR ACTIVE PHARMACEUTICAL INGREDIENTS THERAPEUTIC CATEGORY Pilot Plant Scale Arteether Artemether Carvedilol Clopidogrel bisulphate Rosiglitazone maleate Sulphinpyrazone Antimalarial Antimalarial Antihypertensive Antithrombotic Antidiabetic Antithrombotic R & D Scale Pamidronate disodium Valsartan Antiosteoporotic Antihypertensive Development Benazepril hydrochloride Glipizide Irbesartan Perindopril erbumine Ramipril Risedronic acid Antihypertensive Antidiabetic Antihypertensive Antihypertensive Antihypertensive Antiosteoporotic *The Technical and Physical manufacturing capabilities exist with us for the above  APIs and their intermediates. However   these  products  will  be offered  only  to  the  markets  where any product or  process  patents  are  not infringing. During   the  validity   of  a  patent   the  research  quantities  for  developing  products  for  regulatory submissions will only be offered to countries where such exemption exists (Hatch Waxman Act / Bolar exemption). While Calyx  offers  to  work with  the clients  on  Patent Status  Verification, the final  responsibility vests with the buyer. Recipients are requested to make their evaluation and determination as to the patent  status prior to their use of the information or materials in their respective jurisdiction. # US DMF / EU CoS / Russian Registration + CTD filing under process